TY  - JOUR
A1  - Ehrenstein, Michael R
A1  - Shipa, Muhammad
VL  - 220
UR  - http://doi.org/10.1084/jem.20230559
N2  - In this Viewpoint we discuss how experimental medicine applied in the setting of clinical trials can address unmet need in the prototypic autoimmune disease systemic lupus erythematosus (SLE) to improve outcomes for patients.
AV  - public
JF  - Journal of Experimental Medicine
ID  - discovery10169388
IS  - 6
N1  - © 2023 Ehrenstein and Shipa. This article is distributed under the terms of an Attribution?Noncommercial?Share Alike?No Mirror Sites license for the first six months
after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution?Noncommercial?Share Alike
4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
PB  - Rockefeller University Press
TI  - SLE is not a one-size-fits-all disease
Y1  - 2023/04/25/
SN  - 0022-1007
ER  -